--- type: product title: Anti-acne url: https://www.dmcostech.com/product/nsf-cgmp/anti-acne markdown_url: https://www.dmcostech.com/product/nsf-cgmp/anti-acne.md product_type: simple on_sale: false currency: USD stock_status: instock categories: - NSF & cGMP images: - https://www.dmcostech.com/wp-content/uploads/2025/09/anti-ance-cream.jpg slug: anti-acne published: 2025-10-04T08:59:06Z modified: 2026-07-22T09:12:16Z language: en-US word_count: 850 tokens: 1910 --- # Anti-acne Anti-acne Global Anti-Acne OEM/ODM Solutions: FDA-Compliant Formulas & Clinically Proven Efficacy Expert Manufacturing for Your Acne Treatment Brand As a cGMP-certified facility that has successfully passed FDA on-site audits, we provide a full-service, turnkey solution for global brands seeking to launch effective OTC acne treatment products. Our seamless process covers every stage: Formulation R&D, Regulatory Compliance & Registration, and Full-Scale Production & Delivery. With 20 years of specialized experience in the anti-acne sector, we have developed a portfolio of over 100 proprietary acne-fighting formulas and have proudly served clients in 37 countries. Our expertise spans a wide range of product categories, including: Acne Gels Acne Creams & Lotions Acne Treatment Sprays Our state-of-the-art facility has a monthly production capacity of 4.5 million units. We champion the growth of new and emerging brands by offering flexible manufacturing with a low Minimum Order Quantity (MOQ) starting at just 5,000 units. This approach empowers you to enter the global market with innovative products while minimizing inventory risk. Compliance Support: Your Guide to U.S. OTC Market Entry Regulatory Compliance: Adheres to the FDA's Final Monograph for OTC Acne Drug Products (21 CFR Part 333, Subpart D). Production System: Conforms to cGMP Federal Regulations for pharmaceuticals (21 CFR Parts 210 & 211). The Unique Regulatory Status of Anti-Acne Products Anti-acne Gel In the United States market, products intended for acne treatment are strictly regulated as over-the-counter (OTC) drugs, not as standard cosmetics. Any product claiming to "treat acne" or "reduce pimples" is automatically classified as an OTC drug and must comply with the FDA's official regulations. All products must adhere to the OTC Final Monograph for Acne Treatments (codified in 21 CFR § 333.310). Failure to obtain a National Drug Code (NDC) registration prior to market entry can result in significant penalties, including detention of shipments by U.S. Customs or the issuance of an official FDA Warning Letter. Key regulatory requirements include Active Ingredient Restrictions: Formulations are restricted to a limited list of FDA-approved active ingredients for acne treatment, such as Salicylic Acid or Benzoyl Peroxide, at specified concentrations. Efficacy Verification: All claims related to treating acne must be scientifically substantiated according to FDA standards. Mandatory Labeling: Packaging must feature a standardized "Drug Facts" panel. It must also include specific warnings required for acne products (e.g., "For external use only," "Avoid contact with eyes"). Pharmaceutical GMP Requirements: The manufacturing facility must be fully compliant with the Code of Federal Regulations for drug production (21 CFR Parts 210 & 211). Our End-to-End Compliance Services To address the core challenges of bringing anti-acne products to the U.S. market, we provide a full-process solution: 1. OTC Monograph Pre-Compliance Review Formula Audit: Ensures active ingredient combinations and concentrations comply with the FDA Monograph for OTC Acne Treatments. Label & Claims Review: Verifies all packaging information and marketing claims for regulatory compliance. Toxicological Risk Assessment (TRA) Active Ingredient Assay (Potency Test) USP <51> Antimicrobial Effectiveness Test USP <61> & <62> Microbiological Examination of Nonsterile Products Clinical Efficacy Testing for Anti-Acne Claims Additional Chemical Testing: Heavy Metals (Lead, Cadmium, Mercury), 1,4-Dioxane, and Water Activity. Dermatological Safety & Hypoallergenic Testing (e.g., HRIPT) 2. NDC Number Application & OTC Drug Listing We obtain your NDC code in an average of 15 days, compared to the 45-day industry average. 3. Optimized Testing Programs We coordinate with FDA-recognized, GMP-qualified testing laboratories. This approach can reduce redundant testing costs by 30%. 4. GMP Compliance Support Our facility design and operational protocols are fully compliant with pharmaceutical cGMP requirements (21 CFR 210/211). Breakthrough Technology: Triple-Encapsulation System Traditional acne creams can be harsh and irritating. Market data shows that 78% of users with acne-prone skin discontinue product use due to irritation from aggressive ingredients, leaving a significant gap for effective yet gentle solutions. Our Solution: A Gentle, High-Efficacy, Clinically-Tested Formula We have engineered a low-irritation formula system that delivers superior results without compromising skin comfort, a claim validated by clinical Human Repeat Insult Patch Tests (HRIPT). Breakthrough Technology: Triple-Encapsulation System Our innovative formula utilizes a multi-layered encapsulation technology to deliver active ingredients precisely and over time, maximizing efficacy while minimizing irritation. 1. Outer Layer: Fast-Acting Salicylic Acid Provides rapid anti-inflammatory action to visibly calm redness and breakouts, with effects starting in just 2 hours. 2. Core Layer: Sustained-Release Pionin® Features a core of Pionin®, a powerful antibacterial agent. Its 8-hour sustained-release mechanism continuously inhibits acne-causing bacteria, preventing future flare-ups. 3. Repair Layer: Red Algae Extract Forms the final layer to actively repair the skin's natural barrier. This is clinically proven by a 32% reduction in Trans-Epidermal Water Loss (TEWL). Performance and Safety Comparison Metric Our Advanced Technology Traditional Formula Transdermal Absorption (8h) 105 µg/cm² 41 µg/cm² Skin Erythema Index 0.3 (Minimal Irritation) 2.1 (High Irritation) This data shows our technology enhances absorption while significantly reducing irritation compared to traditional formulas. Clinical Efficacy vs. Competitors Our formula demonstrates statistically significant improvements in key efficacy metrics compared to the average competitor product. Efficacy Dimension Our Formula Competitor Average Inflammatory Acne Reduction 63% (in 28 days) 48% Skin Barrier Repair +32% Improvement +15% Improvement Blackhead Clearing Power ★★★★☆ ★★★☆☆